HTR5A and Parkinson disease: Because the 5HT system appears to supply most of the striatal DA in late PD as an assumed (so-called) “false” neurotransmitter derived from levodopa (see earlier in this review), differences in this system are expected to affect OFF-phase and LID occurrences.